Source: Metabolites. Unidade: FOB
Subjects: FARMACOGENÉTICA, LÍQUIDOS CORPORAIS, POLIMORFISMO
ABNT
OLIVEIRA, Gabriela de Moraes et al. CYP2C9 polymorphism influence in PK/PD model of naproxen and 6-O-Desmethylnaproxen in oral fluid. Metabolites, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3390/metabo12111106. Acesso em: 20 ago. 2024.APA
Oliveira, G. de M., Dionisio, T. J., Siqueira-Sandrin, V. da S., Ferrari, L. A. de L., Bolani, B., Parisi, V. A., et al. (2022). CYP2C9 polymorphism influence in PK/PD model of naproxen and 6-O-Desmethylnaproxen in oral fluid. Metabolites, 12. doi:10.3390/metabo12111106NLM
Oliveira G de M, Dionisio TJ, Siqueira-Sandrin V da S, Ferrari LA de L, Bolani B, Parisi VA, Polanco NLDH, Colombini-Ishikiriama BL, Faria FAC de, Santos CF dos, Calvo AM. CYP2C9 polymorphism influence in PK/PD model of naproxen and 6-O-Desmethylnaproxen in oral fluid [Internet]. Metabolites. 2022 ; 12[citado 2024 ago. 20 ] Available from: https://doi.org/10.3390/metabo12111106Vancouver
Oliveira G de M, Dionisio TJ, Siqueira-Sandrin V da S, Ferrari LA de L, Bolani B, Parisi VA, Polanco NLDH, Colombini-Ishikiriama BL, Faria FAC de, Santos CF dos, Calvo AM. CYP2C9 polymorphism influence in PK/PD model of naproxen and 6-O-Desmethylnaproxen in oral fluid [Internet]. Metabolites. 2022 ; 12[citado 2024 ago. 20 ] Available from: https://doi.org/10.3390/metabo12111106